TABLETING PROPERTIES OF THERMALLY ACTIVATED COW BONE POWDER IN HIGH DOSE FORMULATION
Journal Title: International Journal of Pharmaceutical Development & Technology - Year 2016, Vol 6, Issue 2
Abstract
ABSTRACT Activated cow bone powder was evaluated and found suitable as a diluent in the formulation of low and high dose drugs. This study was conducted in order to compare the diluent properties of dicalcium phosphate (DCP) and activated bone powder (ABP) in the formulation of high dose drugs. The mixed powders were pelletized with the specac pelletization machine, using a compaction force between 10-20 metric tonnes. A sample weight of 666 mg of the granules was used to calibrate the volumetric fill of the die using 12.5 mm punch and die set. The appropriate compression force which varied from 10-20 metric tonnes was applied to compress the granules into tablets. The formulated metronidazole tablet was evaluated for properties such as weight uniformity, thickness, crushing strength, friability, disintegration and organoplastic. Compressibility of the pellets increased with decrease in particle size fractions, and the ABP compressibility was found to be higher than that of DCP. The crushing strength of compacts formed, decreased with increase in initial particle size fraction. The disintegration times were within the acceptable time limit. The hardness of the tablets containing same formulation with ABP compared with DCP was higher in all cases. The friability values of formulations I and II of the tablets ranged between 0.4 to 0.8%, all within the value of not more than 1% standard, normally fixed by most tablet manufacturing industries. The tablet weight variations of <2% showed that the weights of the tablets were uniform. Activated cow bone powder was found to be better direct compressible diluents than the commercially available dicalcium phosphate for high dose drugs such as metronidazole. Keywords: Formulation, Metronidazole, Activated bone powder.
Authors and Affiliations
Emenike IV1* , Timothy SY2 , Okpanachi GO1 , Musa H3
Keywords
Related Articles
- EP ID EP101549
- DOI -
- Views 113
- Downloads 0
ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY OF LEAF EXTRACT OF MORINDA CITRIFOLIA IN EXPERIMENTAL MODELS
Morinda citrifolia is a medium sized evergreen tree belongs to Rubiaceae family. The petroleum ether extract ofMorinda citrifolia (PMC) leaves was investigated for the evaluation of anti- inflammatory and analgesic...
EVALUATION OF IN VITRO ANTIOXIDANT AND GC/MS SPECTROSCOPIC ANALYSIS OF MEMECYLON UMBELLATUM BURM F FOR ITS BIOACTIVE COMPOUNDS
ABSTRACT Medicinal plants plays a major role in the discovery of new therapeutic agents for drug development. In recent times there is more attention towards them, due to the presence of bioactive compounds and t...
SOLID LIPID NANOPARTICLES: FOR ENHANCEMENT OF ORAL BIOAVAILABILITY
Solid lipid nanoparticles are emerging as alternative carriers to colloidal systems for controlled and targeted drug delivery. SLNs combine the advantages of different colloidal carriers, like emulsions, liposome’s...
DEVELOPMENT AND VALIDATION OF DAPOXETINE IN PURE AND SOLID DOSAGE FORM BY HPTLC METHOD
An HPTLC method has been developed for the estimation of Dapoxetine in bulk and solid dosage form. It employs pre coated plates by using silica gel 60 F 254(2×10 cm, thick ness of layer 0.2 mm) as stationary phas...
FORMULATION DEVELOPMENT AND EVALUATION OF POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS
Potassium chloride is an electrolyte replenisher used in the treatment of hypokalemia. It has a short biological half-life of 1 to 1.5hours. It is a freely soluble drug in the gastric contents while taking it ora...